Skip to Content

Erymax 250mg (Erythromycin delayed-release 250 mg)

Pill with imprint Erymax 250mg is Orange / Clear, Capsule-shape and has been identified as Erythromycin delayed-release 250 mg. It is supplied by Midlothian Laboratories.

Erythromycin is used in the treatment of dental abscess; skin or soft tissue infection; upper respiratory tract infection; bronchitis; bacterial endocarditis prevention (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Erymax 250mg

Erythromycin delayed-release

Erymax 250mg
250 mg
Orange / Clear
Prescription only
Drug Class:
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Midlothian Laboratories
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.